NEW YORK--(BUSINESS WIRE)--Ovid Therapeutics Inc. (Ovid), a privately held biopharmaceutical company focused on developing therapies for rare and orphan diseases of the brain, announced today that Dr. Yaron Werber, Ovid’s Chief Financial Officer, will participate on a panel, titled “Rare Diseases – Behind Enzyme Replacement Therapy,” during Citi’s 10th Annual Biotech Conference, taking place at the Mandarin Oriental New York, September 9-10, 2015. The panel will convene on Thursday, September 10, at 9am Eastern Time.
Help employers find you! Check out all the jobs and post your resume.
